Quotes 5-day view Delayed Nasdaq
10/20/2020
10/21/2020
10/22/2020
10/23/2020
10/26/2020
Date
101.92(c)
99.96(c)
102.69(c)
104.71(c)
103.15 Last
755 434
883 226
574 254
615 953
169 950 Volume
-0.80% -1.92% +2.73% +1.97% -1.49% Change
Sales 2020
279 M - -
Net income 2020
-158 M - -
Net cash position 2020
865 M - -
P/E ratio 2020
-65,3x
Yield 2020
-
Sales 2021
380 M - -
Net income 2021
-119 M - -
Net cash position 2021
747 M - -
P/E ratio 2021
-82,3x
Yield 2021
-
Capitalization
10 431 M 10 431 M -
EV / Sales 2020
34,3x
EV / Sales 2021
25,5x
Nbr of Employees
622
Free-Float
92,2%
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection, LUNAR-1 and...
Notations Surperformance© of Guardant Health, Inc.
Trading Rating : Investor Rating :
All news about GUARDANT HEALTH, INC.
News in other languages on GUARDANT HEALTH, INC.
SoftBank's Son says Japan should make AI mandatory subject for college students
Chart GUARDANT HEALTH, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends GUARDANT HEALTH, INC.
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
10
Average target price
116,78 $
Last Close Price
104,71 $
Spread / Highest target
24,2%
Spread / Average Target
11,5%
Spread / Lowest Target
-4,50%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
